TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Yoon Kyung Jeon Bhumsuk Keam |
| Publication date | October 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |